MRI evaluation of breast cancer
Sweeney, K.J.; Sacchini, V.
New England Journal of Medicine 357(2): 192; Author Reply 193
2007
ISSN/ISBN: 0028-4793 PMID: 17626308 Document Number: 607703
Document emailed within 1 workday
Related Documents
Penault-Llorca, F.; Jacquemier, J.; Le Doussal, V.; Voigt, J.J. 1999: Quality challenge for immunohistochemistry: example of the ERBB-2 status in breast cancer. Group for Evaluation of Prognostic Factors in Immunohistochemistry in Breast Cancer (GEFPICS) Annales de Pathologie 19(4): 280-282de Koning, H.J. 1995: Screening for breast cancer, time to think--and stop? National Evaluation Team for Breast Cancer Screening (NETB) Lancet 346(8972): 438-439
Gao, D.-l.; Hu, Y.-w.; Wang, W.-w.; Chen, F.-l.; Pan, L.-d.; Yuan, Y.; Yu, L.-d.; Qian, F. 2006: Evaluation on the effect of intervention regarding breast self-examination for decreasing breast cancer mortality Zhonghua Liu Xing Bing Xue Za Zhi 27(11): 985-990
Pediconi, F.; Venditti, F.; Padula, S.; Roselli, A.; Moriconi, E.; Giacomelli, L.; Catalano, C.; Passariello, R. 2005: CE-Magnetic Resonance Mammography for the evaluation of the contralateral breast in patients with diagnosed breast cancer La Radiologia Medica 110(1-2): 61-68
Shiga, T.; Kawauchi, A.; Kamiya, K.; Ishii, J.; Uzawa, R.; Gomi, K. 1986: Clinical evaluation of serum CA-50 measurement in breast diseases --relation to the progress of breast cancer Rinsho Byori. Japanese Journal of Clinical Pathology 34(11): 1339-1345
Pina Insausti, L.; Pons Renedo, M.J. 2008: Evaluation of the contralateral breast with magnetic resonance in patients with newly diagnosed unilateral breast cancer Revista de Medicina de la Universidad de Navarra 52(1): 37-39
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Carpenter, J.T.; Raney, M.; Logan, T. 1986: Phase Ii evaluation of procarbazine in metastatic breast cancer: a Southeastern Cancer Study Group Trial Cancer Treatment Reports 70(5): 679-680
Schaffer, P.; Renaud, R.; Gairard, B.; Guldenfels, C. 1996: The role of cancer registries in the evaluation of breast cancer screening Revue d'Epidemiologie et de Sante Publique 44(Suppl 1): S15-S21
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Lawson, D.; Moore, M.; Smalley, R. 1980: An evaluation of hexamethylmelamine, cis-diamminedichloroplatinum, and mitomycin-C in advanced breast cancer. a pilot study of the Southeastern Cancer Study Group Cancer Clinical Trials 3(4): 293-296
Shiroiwa, T. 2012: Economic evaluation of treatment on breast cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 7): 798-802
Lytkin, G.V.; Beroev, I.V.; Emel'ianov, S.S.; Makeev, I.M. 1989: Evaluation of radical lymphadenectomy in breast cancer Voprosy Onkologii 35(8): 932-939
Molina, R.; Filella, X.; Alicarte, J.; Zanon, G.; Pahisa, J.; Munoz, M.; Farrus, B.; Ballesta, A.M. 2003: Prospective evaluation of CEA and CA 15.3 in patients with locoregional breast cancer Anticancer Research 23(2a): 1035-1041
Kikuchi, K.; Uematsu, Y.; Takada, Y.; Kurihara, E.; Suito, T.; Fujisaki, M.; Takahashi, R.; Tamura, T. 1987: Evaluation of tumor marker CA15-3 in breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(11): 3095-3100
Semiglazov, V.F. 1985: Evaluation of screening methods in the detection of breast cancer Voprosy Onkologii 31(4): 92-96
Villari, N.; Fargnoli, R.; Mungai, R. 1985: CT evaluation of chest wall recurrences of breast cancer European Journal of Radiology 5(3): 206-208
Reiner, A.S.; Sisti, J.; John, E.M.; Lynch, C.F.; Brooks, J.D.; Mellemkjær, L.; Boice, J.D.; Knight, J.A.; Concannon, P.; Capanu, M.; Tischkowitz, M.; Robson, M.; Liang, X.; Woods, M.; Conti, D.V.; Duggan, D.; Shore, R.; Stram, D.O.; Thomas, D.C.; Malone, K.E.; Bernstein, L.; Bernstein, J.L. 2018: Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 36(15): 1513-1520
Yao, F.Y. 1991: Evaluation of risk factors of the daughters of breast cancer patients Zhonghua Yu Fang Yi Xue Za Zhi 25(5): 285-287
Cazin, J.L.; Gosselin, P.; Boniface, B.; Demaille, M.C.; Demaille, A. 1992: An evaluation of CA 549, a circulating marker of breast cancer using a procedure for comparison with CA 15.3 Anticancer Research 12(3): 719-724